Alex Goldberg

Novavax, Inc. (NASDAQ:NVAX) and American Capital Agency Corp. (NASDAQ:AGNC) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/14/2014 -- -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Novavax, Inc. (NASDAQ:NVAX) and American Capital Agency Corp. (NASDAQ:AGNC).

Novavax, Inc. (NASDAQ:NVAX) a clinical-stage biopharmaceutical company that focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases closed up in its previous session (+6.37%) on 10,625,620 shares traded after Novavax Announced Continuation of RSV Vaccine Partnership With PATH. Novavax, Inc. (NASDAQ:NVAX) is currently up (+243.45%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Novavax, Inc. (NASDAQ:NVAX)

American Capital Agency Corp. (NASDAQ:AGNC) a company that operates as a real estate investment trust closed up in its previous session (+1.54%) on 8,462,144 shares traded. American Capital Agency Corp. (NASDAQ:AGNC) is currently up (+8.92%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about American Capital Agency Corp. (NASDAQ:AGNC)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com